{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:18:19Z","timestamp":1772781499963,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["Progres Q25"],"award-info":[{"award-number":["Progres Q25"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV 260373"],"award-info":[{"award-number":["SVV 260373"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11096-017-0522-7","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T15:34:34Z","timestamp":1502206474000},"page":"1095-1100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adherence with perindopril therapy: a pilot study using therapeutic drug monitoring of perindoprilat and an evaluation of the clearance estimation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-738X","authenticated-orcid":false,"given":"Martin","family":"\u0160\u00edma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Vodi\u010dka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u011bra","family":"Mare\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"\u0160\u00e1lek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radom\u00edr","family":"\u010cabala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Slana\u0159","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"522_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/imj.12975","volume":"46","author":"A Sindone","year":"2016","unstructured":"Sindone A, Erlich J, Lee C, Newman H, Suranyi M, Roger SD. Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to? Intern Med J. 2016;46:364\u201372.","journal-title":"Intern Med J"},{"key":"522_CR2","doi-asserted-by":"crossref","first-page":"e5641","DOI":"10.1097\/MD.0000000000005641","volume":"96","author":"TM Abegaz","year":"2017","unstructured":"Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e5641.","journal-title":"Medicine (Baltimore)"},{"key":"522_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2040622312452189","volume":"3","author":"C Borghi","year":"2012","unstructured":"Borghi C, Tartagni E. The older patient with hypertension: care and cure. Ther Adv Chronic Dis. 2012;3:231\u20136.","journal-title":"Ther Adv Chronic Dis"},{"key":"522_CR4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487\u201397.","journal-title":"N Engl J Med"},{"key":"522_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2125.1998.00770.x","volume":"46","author":"AS Gross","year":"1998","unstructured":"Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol. 1998;46:95\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"522_CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139.","journal-title":"N Engl J Med"},{"key":"522_CR7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","volume":"18","author":"FJ Hoek","year":"2003","unstructured":"Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"522_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/hr.2010.183","volume":"34","author":"J Ceral","year":"2011","unstructured":"Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011;34:87\u201390.","journal-title":"Hypertens Res"},{"key":"522_CR9","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/HJH.0b013e3283652c61","volume":"31","author":"B Strauch","year":"2013","unstructured":"Strauch B, Petr\u00e1k O, Zelinka T, Rosa J, Soml\u00f3ov\u00e1 Z, Indra T, Chytil L, Mare\u0161ov\u00e1 V, Kurcov\u00e1 I, Holaj R, Wichterle D, Widimsk\u00fd J. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens. 2013;31:2455\u201361.","journal-title":"J Hypertens"},{"key":"522_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1991.tb03880.x","volume":"32","author":"GA Verpooten","year":"1991","unstructured":"Verpooten GA, Genissel PM, Thomas JR, De Broe ME. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency. Br J Clin Pharmacol. 1991;32:187\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"522_CR11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1373\/clinchem.2015.243030","volume":"61","author":"JW Meeusen","year":"2015","unstructured":"Meeusen JW, Rule AD, Voskoboev N, Baumann NA, Lieske JC. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. Clin Chem. 2015;61:1265\u201372.","journal-title":"Clin Chem"},{"key":"522_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/48.5.699","volume":"48","author":"OF Laterza","year":"2002","unstructured":"Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem. 2002;48:699\u2013707.","journal-title":"Clin Chem"},{"key":"522_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bcp.12602","volume":"80","author":"NA Brou","year":"2015","unstructured":"Brou NA, Jacqz-Aigrain E, Zhao W. Cystatin C as a potential biomarker for dosing of renally excreted drugs. Br J Clin Pharmacol. 2015;80:20\u20137.","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-017-0522-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:15:13Z","timestamp":1602681313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-017-0522-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1007\/s11096-017-0522-7","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]}}}